微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.15% | -87.18% | 0% | 110/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.15% | 188.24% | 146.88% | 110/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -0.32% | -900% | 74.8% | 119/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -1.27% | 16.45% | -208.55% | 109/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 1.17% | -4.1% | 788.24% | 107/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -0.17% | -128.81% | -525% | 115/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.04% | -92.98% | 102.63% | 118/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -1.52% | 14.61% | -224.59% | 111/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 1.22% | -42.18% | 106.78% | 102/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.59% | -62.18% | 3.51% | 108/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.57% | -47.22% | 132.02% | 104/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -1.78% | -152.05% | -184.36% | 116/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.11% | -49.52% | 35.26% | 104/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.56% | -45.07% | 44.44% | 103/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.08% | -33.33% | -68.42% | 92/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 3.42% | -27.08% | -18.18% | 94/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 4.18% | -32.69% | 47.18% | 78/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.84% | -33.49% | 75.31% | 76/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.62% | -28.32% | -65.46% | 59/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.69% | -74.8% | -24.48% | 88/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.21% | -58.32% | 45.43% | 56/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.27% | -53.79% | 88.94% | 61/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.26% | -41.15% | -87.86% | 50/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 18.61% | -2.16% | 24.9% | 20/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 14.9% | -4.3% | 61.26% | 11/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 9.24% | -13.4% | 140.63% | 13/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.84% | -9.65% | -79.81% | 19/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 19.02% | -46.74% | 22.16% | 13/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 15.57% | -47.22% | 45.92% | 12/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 10.67% | 546.44% | 151.06% | 14/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 4.25% | -49.28% | -88.1% | 9/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 35.71% | 7242% | 21.05% | 3/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 29.5% | 4438.46% | 1334.31% | 1/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -2.39% | -846.88% | -128.52% | 88/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 8.38% | 1610.2% | 1776% | 3/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -0.5% | -394.12% | -176.92% | 95/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 0.65% | -80.83% | 103.13% | 70/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.32% | 12207.69% | -34.69% | 74/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.49% | -27.94% | 188.24% | 62/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 0.17% | 104.42% | -94.99% | 91/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 3.39% | 149.78% | 130284.6% | 52/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 0% | 100.05% | -99.62% | 63/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 0.68% | 135.42% | 117.66% | 54/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |